Clinical Trials Logo

Clinical Trial Summary

Identify by culture the urinary microbiota of patients with bladder cancer (at the time of diagnosis) and controls.Identify by metagenomics the urinary microbiota of patients with bladder cancer (at the time of diagnosis) and controls.


Clinical Trial Description

Relationships between the human microbiota and various pathologies such as cancer have been demonstrated. The microbiota would have an influence on the effectiveness of anticancer treatments.

Bladder cancers are five times more common in men than women, and this difference in incidence has long been explained by a higher smoking rate among men. However, the increase in smoking among women has not led, as in the case of lung cancer, to a significant increase in bladder cancer among them.

Urine bladder has long been considered "sterile" by generations of researchers. Recent studies have shown that most urine is not sterile but instead contains a different microbiota in both men and women. In women Actinobacteria, including Mycobacteria, and Bacteroidetes have been detected.

BCG therapy is used in the treatment of bladder cancer. BCG, in addition to being a vaccine to prevent tuberculosis, is a mycobacterium belonging to the phylum Actinobacteria [4]. Controversial studies have suggested the same potential for Lactobacillus casei. Lactobacillii are Firmicutes found both in the urinary microbiota of men and women.

Thus microbiota composed mainly of Actinobacteria could be associated with a lower incidence of bladder cancers in women. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04019756
Study type Observational [Patient Registry]
Source Assistance Publique Hopitaux De Marseille
Contact Didier Raoult
Phone 04 13 73 24 01
Email didier.raoult@gmail.com
Status Not yet recruiting
Phase
Start date September 1, 2019
Completion date September 30, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT00563069 - Premedication With Oral Midazolam in Patients Undergoing Rigid Cystoscopy: A Randomized, Double-blind, Placebo-controlled Trial N/A
Active, not recruiting NCT03138824 - Storz Professional Image Enhancement System Versus White Light Imaging Assisted TURBT for Treatment of NMIBC N/A
Recruiting NCT05415631 - Augmented Bladder Tumor Detection Using Real Time Based Artificial Intelligence
Completed NCT02960412 - Effect of Furosemide on Confirmation of Ureteral Patency During Routine Cystoscopy Phase 4
Recruiting NCT06342193 - Effect of Virtual Reality Glasses on Anxiety During Cystoscopy: A Randomised Controlled Trial N/A
Completed NCT04595344 - Effects of Listening to Binaural Beats on Anxiety and Pain Scores in Males Undergoing Cystoscopy and Stent Removal N/A
Completed NCT05190939 - The Use of Dye-less Cystoscopy in Assessing Urinary Tract Integrity During Hysterectomy N/A
Completed NCT06235853 - Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer
Active, not recruiting NCT03347721 - Does Lidocaine Gel Decrease Pain Perception in Women Undergoing Diagnostic Flexible Cystoscopy Phase 4
Not yet recruiting NCT04440579 - Utilization of PTNS During Office-Based Cystoscopy N/A
Completed NCT04829461 - Effectiveness of Ambu® aScope™ 4 Cysto With the aView™ 2 Advance for Flexible Cystoscopy N/A
Completed NCT02424149 - Phenazopyridine for Confirmation of Ureteral Patency N/A
Completed NCT04413175 - Effects of Music Therapy on Procedural Pain, Anxiety and Comfort Level During Cystoscopy N/A
Active, not recruiting NCT02715648 - Using Phenazopyridine for In-office Cystoscopy N/A